2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Corte-Real J et al. Selective factors governing in vitro β-carotene bioaccessibility: negative influence of low filtration cutoffs and alterations by emulsifiers and food matrices. 2014 Nutr Res pmid:25476193
Quiñones OG et al. In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib. 2014 Drug Dev Ind Pharm pmid:23826859
Thapa RK and Yoo BK Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation. 2014 J Dermatolog Treat pmid:23210668
Zhou Y et al. Biological artificial fluid-induced non-lamellar phases in glyceryl monooleate: the kinetics pathway and its digestive process by bile salts. 2014 Drug Dev Ind Pharm pmid:23350691
Madheswaran T et al. Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants. 2014 AAPS PharmSciTech pmid:24222268
Morsi NM et al. Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. 2014 Eur J Pharm Biopharm pmid:23688805
Esposito E et al. Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin. 2014 Eur J Pharm Biopharm pmid:24361485
Lopez-Bermudez J et al. Oral immunization against porcine pleuropneumonia using the cubic phase of monoolein and purified toxins of Actinobacillus pleuropneumoniae. 2014 Vaccine pmid:25446832
Baskaran R et al. Entrapment of curcumin into monoolein-based liquid crystalline nanoparticle dispersion for enhancement of stability and anticancer activity. 2014 Int J Nanomedicine pmid:25061290
Estracanholli EA et al. Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies. 2014 AAPS PharmSciTech pmid:24980082
Souza C et al. Mucoadhesive system formed by liquid crystals for buccal administration of poly(hexamethylene biguanide) hydrochloride. 2014 J Pharm Sci pmid:25336429
Vargas JN et al. Fast membrane hemifusion via dewetting between lipid bilayers. 2014 Soft Matter pmid:25330351
Maselko J et al. Emergence of complex behavior in chemical cells: the system AlCl₃-NaOH. 2014 Langmuir pmid:24805150
Cohen-Avrahami M et al. HIV-TAT enhances the transdermal delivery of NSAID drugs from liquid crystalline mesophases. 2014 J Phys Chem B pmid:24798650
Kolev VL et al. Unit cell structure of water-filled monoolein into inverted hexagonal (H(II)) mesophase modeled by molecular dynamics. 2014 J Phys Chem B pmid:24787641
Ghattas N et al. Monoolein production by triglycerides hydrolysis using immobilized Rhizopus oryzae lipase. 2014 Int. J. Biol. Macromol. pmid:24755261
Oliveira AC et al. Dioctadecyldimethylammonium:monoolein nanocarriers for efficient in vitro gene silencing. 2014 ACS Appl Mater Interfaces pmid:24712543
Bitan-Cherbakovsky L et al. Reversed hexagonal lyotropic liquid-crystal and open-shell glycodendrimers as potential vehicles for sustained release of sodium diclofenac. 2014 J Phys Chem B pmid:24617448
Tiossi RF et al. In vitro and in vivo evaluation of the delivery of topical formulations containing glycoalkaloids of Solanum lycocarpum fruits. 2014 Eur J Pharm Biopharm pmid:24509413
Evenbratt H et al. In vivo study of an instantly formed lipid-water cubic phase formulation for efficient topical delivery of aminolevulinic acid and methyl-aminolevulinate. 2013 Int J Pharm pmid:23727140